Add to ORKGThe development of donor specific human leukocyte antigen (HLA) antibodies (DSA) as already been identified as a risk factor for graft dysfuntion and poor survival in teh context of lung transplantation (LuTx), but available evidence is not conclusive. The aim of the study was to evaluate the possibly existing correlation between pre-existing and/or post transplant developing DSA and recipients' outcome
The presence of donor-specific anti-HLA antibodies (DSA) is associated with increased risk of graft ...
Copyright © 2013 Michał Ciszek et al. This is an open access article distributed under the Creative ...
Preformed HLA donor-specific antibodies (DSA) only detected with Luminex have been associated with i...
The impact of de novo donor-specific anti-HLA-antibodies (donor-specific antibody [DSA]) on outcomes...
Donor-specific antibodies (DSA) to mismatched human leukocyte antigens (HLA) are associated with wor...
Chronic lung allograft dysfunction (CLAD) is a limiting factor for long-term survival in lung transp...
Pre-existing HLA antibodies are a well-established causal factor for rejection and graft dysfunction...
Abstract Background Previous studies have suggested that antibodies against human leukocyte antigen ...
Background. The importance of HLA mismatch in determining long-term outcome in lung transplantation ...
OBJECTIVES Human leucocyte antigen (HLA) mismatch between donor and recipient has a differential imp...
Human leukocyte antigen G (HLA-G) expression is thought to be associated with a tolerance state foll...
Background Bronchiolitis obliterans syndrome (BOS) is the major cause of late graft failure after...
AbstractObjective: A retrospective analysis was performed to examine the role of HLA antibodies and ...
Determining the presence of anti-HLA antibodies before transplantation is an important factor to pre...
Abstract Purpose Induction immunosuppression has improved the long‐term outcomes after lung transpla...
The presence of donor-specific anti-HLA antibodies (DSA) is associated with increased risk of graft ...
Copyright © 2013 Michał Ciszek et al. This is an open access article distributed under the Creative ...
Preformed HLA donor-specific antibodies (DSA) only detected with Luminex have been associated with i...
The impact of de novo donor-specific anti-HLA-antibodies (donor-specific antibody [DSA]) on outcomes...
Donor-specific antibodies (DSA) to mismatched human leukocyte antigens (HLA) are associated with wor...
Chronic lung allograft dysfunction (CLAD) is a limiting factor for long-term survival in lung transp...
Pre-existing HLA antibodies are a well-established causal factor for rejection and graft dysfunction...
Abstract Background Previous studies have suggested that antibodies against human leukocyte antigen ...
Background. The importance of HLA mismatch in determining long-term outcome in lung transplantation ...
OBJECTIVES Human leucocyte antigen (HLA) mismatch between donor and recipient has a differential imp...
Human leukocyte antigen G (HLA-G) expression is thought to be associated with a tolerance state foll...
Background Bronchiolitis obliterans syndrome (BOS) is the major cause of late graft failure after...
AbstractObjective: A retrospective analysis was performed to examine the role of HLA antibodies and ...
Determining the presence of anti-HLA antibodies before transplantation is an important factor to pre...
Abstract Purpose Induction immunosuppression has improved the long‐term outcomes after lung transpla...
The presence of donor-specific anti-HLA antibodies (DSA) is associated with increased risk of graft ...
Copyright © 2013 Michał Ciszek et al. This is an open access article distributed under the Creative ...
Preformed HLA donor-specific antibodies (DSA) only detected with Luminex have been associated with i...